Diese Seite wurde automatisch übersetzt und die Genauigkeit der Übersetzung wird nicht garantiert. Bitte wende dich an die englische Version für einen Quelltext.

Personalized and Scalable Cognitive Remediation Approaches

19. Juni 2026 aktualisiert von: Alice Medalia, New York State Psychiatric Institute
The purpose of this study is to develop and pilot test personalized and scalable approaches to Cognitive Remediation (CR) for schizophrenia and schizoaffective disorder. The intent is to more clearly define the therapeutic targets important to the facilitation of cognitive and functional improvement so that clinicians know how to customize cognitive interventions and deliver treatment in a more effective, efficient and personally relevant manner.

Studienübersicht

Status

Abgeschlossen

Intervention / Behandlung

Detaillierte Beschreibung

There are three phases of this study.

Phase 1: Development and Adaptation. The goal of this phase is to adapt currently used computer based CR approaches to make them more personalized and scalable. We will create two CR interventions which differ in choice and pacing of the cognitive exercises. This phase is complete.

Phase 2: Open Trial and Intervention Refinement. The goal of this phase is to obtain quantitative and qualitative feedback on the acceptability and usability of the interventions from participants to inform further refinement of the assessment and treatment packages. We will recruit ten subjects from an outpatient psychiatric rehabilitation program in New York City. After determining study eligibility, individuals will complete a standardized neuropsychological battery for schizophrenia assessment, and a 5-minute Tone Matching Test to assess basic auditory processing. Participants will be randomly assigned to receive one of two intervention packages, developed in Phase 1. Each session includes 60 minutes of computer-based learning activities and a 15 minute therapist-led discussion that links the computer activities to cognition as applied to daily tasks and recovery goals. Participants will complete a total of 10 sessions attending 2-3 times weekly for 5 weeks. During each session, participants will be asked to keep a log of software used. At the conclusion of this abbreviated trial, the participants will participate in focus groups in which they will be asked to provide verbal feedback on how enjoyable, engaging, and useful they perceived the computer and discussion based exercises to be. Participants will be asked to provide verbal feedback on the assessment procedures. CR clinicians will join the research team to discuss participants' engagement and their experience with administering the Tone Matching Test and interventions. Qualitative data summarized from participant logs and focus groups will be considered by the research team to refine the assessment battery, treatment parameters, and rubric of learning exercises. This phase is complete.

Phase 3: Pilot Feasibility Trial. People with a diagnosis of schizophrenia or schizoaffective disorder may be referred by their treating clinician or may respond to posted advertisements to inquire about study participation. After being informed of study procedures, interested individuals will be asked to sign a consent form that documents willingness to participate in this study. Following informed consent, participants will be asked questions about demographic characteristics (e.g. age, education, employment), medication and psychosocial treatment status, psychiatric symptoms and symptoms severity, and will complete a brief assessment of estimated Intelligence. Those with an Intelligence Quotient (IQ) estimate below 70 or meeting substance dependence criteria at the time of evaluation will be exited from the study. In the same or second assessment session, participants will complete assessments of neuropsychological ability, current functioning, and motivation for treatment. Participants will then be randomly assigned to one of two treatment conditions named "Brain Basics" or "Brain Exercises".

Each treatment condition is structured in a group format of up to 5 participants. Both treatments use commercially available computer-based training software to exercise cognitive skills such as speed of processing, attention, working memory, and verbal memory. Both conditions will entail 50 minutes on the computer and 10 minutes group discussion. In the discussion, participants review the cognitive activities they are working on and how they will help them achieve their recovery goals. The treatment phase will consist of 30 separate sessions each 60 minutes in duration, administered 3 times a week over the course of a 10-week period. Participants will be re-tested on outcome measures approximately 1 week following end of treatment, and again 3 months later.

Studientyp

Interventionell

Einschreibung (Tatsächlich)

115

Phase

  • Unzutreffend

Kontakte und Standorte

Dieser Abschnitt enthält die Kontaktdaten derjenigen, die die Studie durchführen, und Informationen darüber, wo diese Studie durchgeführt wird.

Studienorte

    • New York
      • Brooklyn, New York, Vereinigte Staaten, 11206
        • Williamsburg Clinic
      • Brooklyn, New York, Vereinigte Staaten, 11207
        • Institute for Community Living
      • New York, New York, Vereinigte Staaten, 10032
        • Nyspi/ Cumc
      • New York, New York, Vereinigte Staaten, 10040
        • The Bridge Inc
      • The Bronx, New York, Vereinigte Staaten, 10467
        • FEGS Bronx Mental Health Clinic

Teilnahmekriterien

Forscher suchen nach Personen, die einer bestimmten Beschreibung entsprechen, die als Auswahlkriterien bezeichnet werden. Einige Beispiele für diese Kriterien sind der allgemeine Gesundheitszustand einer Person oder frühere Behandlungen.

Zulassungskriterien

Studienberechtigtes Alter

18 Jahre bis 65 Jahre (Erwachsene, Älterer Erwachsener)

Akzeptiert gesunde Freiwillige

Nein

Beschreibung

Inclusion Criteria:

  1. Diagnostic and Statistical Manual-IV (DSM-IV) diagnosis of schizophrenia or schizoaffective disorder
  2. Age 18 to 65
  3. English speaking
  4. Psychiatrically stable, verified by current living/treatment status

Exclusion Criteria:

  1. Indication of mental retardation, determined by estimated IQ of less than 70
  2. Hearing or visual impairment that precludes completing assessments
  3. Neurologic illness that may affect brain physiology (e.g. Parkinson's, seizure disorder, epilepsy)
  4. Current substance dependence symptoms in the past 6 weeks
  5. Participation in cognitive remediation in the 12 months prior to study entry.

Studienplan

Dieser Abschnitt enthält Einzelheiten zum Studienplan, einschließlich des Studiendesigns und der Messung der Studieninhalte.

Wie ist die Studie aufgebaut?

Designdetails

  • Hauptzweck: Behandlung
  • Zuteilung: Zufällig
  • Interventionsmodell: Parallele Zuordnung
  • Maskierung: Single

Waffen und Interventionen

Teilnehmergruppe / Arm
Intervention / Behandlung
Aktiver Komparator: Brain Basics for Impaired Tone Matchers
Cognitive remediation includes sensory processing training
Cognitive remediation sessions include working on computer based cognitive exercises and participating in a verbal discussion.
Aktiver Komparator: Brain Basics for Intact Tone Matchers
Cognitive remediation includes sensory processing training
Cognitive remediation sessions include working on computer based cognitive exercises and participating in a verbal discussion.
Aktiver Komparator: Brain Training for Impaired Tone Matcher
Cognitive remediation does not include sensory processing training
Cognitive remediation sessions include working on computer based cognitive exercises and participating in a verbal discussion.
Aktiver Komparator: Brain Training for Intact Tone Matchers
Cognitive remediation does not include sensory processing training
Cognitive remediation sessions include working on computer based cognitive exercises and participating in a verbal discussion.

Was misst die Studie?

Primäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Feasibility of Enrollment, Randomization and Retention
Zeitfenster: Two years
Feasibility is measured by enrollment, acceptability of randomization defined as number initiated allocated treatment, retention of subjects defined as number completed allocated treatment
Two years

Sekundäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Change in Neurocognition From Baseline to Treatment End-point
Zeitfenster: 10 weeks
Change in neurocognition is calculated as the difference in the MATRICS Consensus Cognitive Battery Neurocognitive Composite Score between baseline and treatment end-point (10 weeks). The MATRICS Consensus Cognitive Battery Neurocognitive Composite T-Score is a scaled score calculated from the following component subscales: a) working memory; b) attention/vigilance; c) verbal learning; d) visual learning; e) processing speed; f) reasoning and problem solving. The mean T-score is 50 with a standard deviation of 10. Higher scores on the scale mean better outcomes. Higher change scores mean better outcomes.
10 weeks
Change in Neurocognition From Baseline to 3-month Follow-up
Zeitfenster: 5.5 to 6 months
Change in neurocognition is calculated as the difference in the MATRICS Consensus Cognitive Battery Neurocognitive Composite Score between baseline and 3-month follow-up (5.5 to 6 months). The MATRICS Consensus Cognitive Battery Neurocognitive Composite T-Score is a scaled score calculated from the following component subscales: a) working memory; b) attention/vigilance; c) verbal learning; d) visual learning; e) processing speed; f) reasoning and problem solving. The mean T-score is 50 with a standard deviation of 10. Higher scores on the scale mean better outcomes. Higher change scores mean better outcomes.
5.5 to 6 months

Andere Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Intrinsic Motivation Inventory for Schizophrenia Research (IMI-SR)
Zeitfenster: 10 weeks
Intrinsic Motivation Inventory for Schizophrenia Research (IMI-SR), a 21 item 7-point Likert type scale designed to assess a participant's subjective experience of an activity, specifically in an experimental setting (e.g. "I enjoyed doing this activity very much"). The IMI-SR will be administered at the first and last treatment sessions.
10 weeks
Perceived Competency Scale (PCS)
Zeitfenster: 10 weeks
The PCS consists of 4 items on a 7-point Likert-type scale that assess feelings of competency when performing computer-based learning activities, with higher scores indicating greater perceived competency. The PCS will be administered at the first and last treatment sessions.
10 weeks
Change in Tone Matching Ability From Baseline to Treatment End-point
Zeitfenster: 10 weeks
Change in Tone Matching (percent correct) will be calculated as the difference between scores measured at baseline and treatment end-point (10 weeks), using pairs of 100-ms tones in series, with 500-ms inter-tone interval. The values on this scale range from 0% to 100% where higher scores mean better outcomes. Higher change scores mean better outcomes.
10 weeks
Change in UCSD Performance-Based Skills Assessment (UPSA)-Brief From Baseline to Treatment End-point
Zeitfenster: 10 weeks
The UPSA - Brief is a proxy measure of daily functioning skills. Change from baseline to treatment end-point (10 weeks) will be assessed as the difference between the two scores. The scale score can range from 0 to 100. Higher scores mean better outcomes. Higher change scores mean better outcomes.
10 weeks
Structured Clinical Interview for the Positive and Negative Syndrome Scale (SCI-PANSS) - Treatment End-point
Zeitfenster: 10 weeks
The SCI-PANSS is a semi-structured interview containing 30 items that assess symptoms of psychotic disorders including positive, negative and general psychopathology. Change from baseline to treatment end-point (10 weeks) will be assessed. Higher scores mean higher symptom severity. Change is calculated as the difference between the two scores. Greater change scores mean greater symptom improvement.
10 weeks
Change in Tone Matching Ability From Baseline to 3-month Follow up
Zeitfenster: 5.5 to 6 months
Change in Tone Matching (percent correct) will be calculated as the difference in scores assessed at baseline and 3-month follow-up (5.5 to 6 months), using pairs of 100-ms tones in series, with 500-ms inter-tone interval. The values on this scale range from 0% to 100% where higher scores mean better outcomes. Greater change scores mean greater improvement.
5.5 to 6 months
Change in UCSD Performance-Based Skills Assessment (UPSA)-Brief From Baseline to 3-month Follow-up
Zeitfenster: 5.5 to 6 months
The UPSA-Brief is a proxy measure for daily functioning skills. The scale score ranges from 0-100. Change from baseline to 3-month follow-up (5.5-6 months) will be assessed as the difference between the two scores. Higher scores mean better outcomes. Higher change scores mean better outcomes.
5.5 to 6 months
Structured Clinical Interview for the Positive and Negative Syndrome Scale (SCI-PANSS) - 3-month Follow-up
Zeitfenster: 5.5 to 6 months
The SCI-PANSS is a semi-structured interview containing 30 items that assess symptoms of psychotic disorders including positive, negative and general psychopathology. Change from baseline to 3-month follow-up will be assessed.
5.5 to 6 months

Mitarbeiter und Ermittler

Hier finden Sie Personen und Organisationen, die an dieser Studie beteiligt sind.

Ermittler

  • Hauptermittler: Alice Medalia, PhD, NYSPI

Publikationen und hilfreiche Links

Die Bereitstellung dieser Publikationen erfolgt freiwillig durch die für die Eingabe von Informationen über die Studie verantwortliche Person. Diese können sich auf alles beziehen, was mit dem Studium zu tun hat.

Studienaufzeichnungsdaten

Diese Daten verfolgen den Fortschritt der Übermittlung von Studienaufzeichnungen und zusammenfassenden Ergebnissen an ClinicalTrials.gov. Studienaufzeichnungen und gemeldete Ergebnisse werden von der National Library of Medicine (NLM) überprüft, um sicherzustellen, dass sie bestimmten Qualitätskontrollstandards entsprechen, bevor sie auf der öffentlichen Website veröffentlicht werden.

Haupttermine studieren

Studienbeginn

1. September 2013

Primärer Abschluss (Tatsächlich)

2. Oktober 2017

Studienabschluss (Tatsächlich)

20. März 2019

Studienanmeldedaten

Zuerst eingereicht

13. September 2013

Zuerst eingereicht, das die QC-Kriterien erfüllt hat

13. September 2013

Zuerst gepostet (Geschätzt)

18. September 2013

Studienaufzeichnungsaktualisierungen

Letztes Update gepostet (Tatsächlich)

17. Juli 2026

Letztes eingereichtes Update, das die QC-Kriterien erfüllt

19. Juni 2026

Zuletzt verifiziert

1. Juni 2026

Mehr Informationen

Begriffe im Zusammenhang mit dieser Studie

Plan für individuelle Teilnehmerdaten (IPD)

Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?

NEIN

Beschreibung des IPD-Plans

This trial started enrolling participants before January 1, 2019.

Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .

Klinische Studien zur Cognitive remediation

3
Abonnieren